KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $109.0 million.

  • Boston Scientific's Restructuring Costs rose 262500.0% to $109.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $194.0 million, marking a year-over-year increase of 111250.0%. This contributed to the annual value of $194.0 million for FY2025, which is 111250.0% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Restructuring Costs is $109.0 million, which was up 262500.0% from -$8.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Restructuring Costs high stood at $298.0 million for Q2 2021, and its period low was -$111.0 million during Q3 2023.
  • Moreover, its 5-year median value for Restructuring Costs was $9.0 million (2021), whereas its average is $39.8 million.
  • In the last 5 years, Boston Scientific's Restructuring Costs skyrocketed by 983333.33% in 2021 and then crashed by 287500.0% in 2023.
  • Boston Scientific's Restructuring Costs (Quarter) stood at $128.0 million in 2021, then increased by 2.34% to $131.0 million in 2022, then plummeted by 184.73% to -$111.0 million in 2023, then soared by 103.6% to $4.0 million in 2024, then soared by 2625.0% to $109.0 million in 2025.
  • Its Restructuring Costs was $109.0 million in Q4 2025, compared to -$8.0 million in Q3 2025 and $83.0 million in Q2 2025.